The fate and risk assessment of psychiatric pharmaceuticals from psychiatric hospital effluent

Xiang, Jiajia; Wu, Minghong; Lei, Jianqiu; Fu, Chao; Gu, Ji; Xu, Gang

doi:10.1016/j.ecoenv.2017.12.049

Cited by 57 publications

(8 citation statements)

References 57 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The contribution of hospital wastewater in the load of pharmaceuticals in municipal wastewater is stated to be significant by some researchers (Santos et al 2013;Azuma et al 2019). On the other hand, some authors claim that the volume of hospital wastewater is low and is a minor contribution to municipal wastewater (Kümmerer 2009;Cruz-Morató et al 2014), or surface water (Xiang et al 2018). What is indisputable is that there are classes of pharmaceuticals which were detected in higher concentrations in hospital wastewater, like those used only in hospitals (Le Corre et al 2012) (for example, antipsychotic pharmaceuticals (Reichert et al 2019)).…”

Section: Hospital Wastewatermentioning

confidence: 99%

How to decrease pharmaceuticals in the environment? A review

Caban

Stepnowski

2021

Environ Chem Lett

View full text Add to dashboard Cite

The global problem of the presence of human and veterinary pharmaceuticals in the environment is under investigation. Despite the increase in the knowledge of its sources, fates and impacts, the assessment of risks and the derived prevention actions are limited to single cases. The predicted increasing trend in the usage of pharmaceuticals forces the various parties involved to think about comprehensive mitigation actions. There are many areas of daily human life and industrial operations where such actions should take place. Thereby, in the presented review, such actions were summarized and divided into the following groups: A. design, synthesis and production of pharmaceuticals, B. prescription, sales and waste handling, C. control of the sources with advanced technologies. As the total amount of proposed actions was found to be quite high, a ranking according to the term of effects was proposed using the pyramid of needs. The advantages of actions taken in the first steps of the pharmaceutical life cycle (acting on the upstream) over end-of-pipe actions and the application of advanced technologies (the downstream option) were discussed, with reference to expert opinions.

show abstract

Section: Hospital Wastewatermentioning

confidence: 99%

How to decrease pharmaceuticals in the environment? A review

Caban

Stepnowski

2021

Environ Chem Lett

View full text Add to dashboard Cite

show abstract

“…With the currently available information, it can be clearly seen that EPCs bioaccumulate in animal and plant tissues and often persist in the environment. 14,15 For example, antibiotic presence in water and related ecosystems is already leading to an increase in antibiotic resistant bacteria. 9,16 More alarming is the amount of these contaminants ending up in effluent streams as a result of their continuous usage in the treatment of various diseases.…”

Section: Introductionmentioning

confidence: 99%

Nano-based adsorbent and photocatalyst use for pharmaceutical contaminant removal during indirect potable water reuse

et al. 2020

View full text Add to dashboard Cite

Increasing human activity, including commercial and noncommercial use of pharmaceuticals, personal care products, and agricultural products, has introduced new contaminants that can be challenging to remove with currently available technologies. Pharmaceuticals, in particular, can be especially challenging to remove from the water supply and can pose great harm to people and local ecosystems. Their highly stable nature makes their degradation with conventional water treatment techniques difficult, and studies have shown that even advanced treatment of water is unable to remove some compounds. As such, decontamination of water from pharmaceuticals requires the development of advanced technologies capable of being used in indirect and direct potable water reuse. In this review, we discuss pharmaceutical removal in indirect potable water treatment and how recent advancements in adsorption and photocatalysis technologies can be used for the decontamination of pharmaceutical-based emerging contaminants. For instance, new materials that incorporate graphene-based nanomaterials have been developed and shown to have increased adsorptive capabilities toward pharmaceuticals when compared with unmodified graphene. In addition, adsorbents have been incorporated in membrane technologies, and photocatalysts have been combined with magnetic material and coated on optical fibers improving their usability in water treatment. Advancements in photocatalytic material research have enabled the development of highly effective materials capable of degradation of a variety of pharmaceutical compounds and the development of visible-light photocatalysts. To understand how adsorbents and photocatalysts can be utilized in water treatment, we address the benefits and limitations associated with these technologies and their potential applicability in indirect potable water reuse plants.

show abstract

“…This is mainly due to greater attenuation and lower use of pharmaceuticals in summer. Thus, pharmaceuticals and their metabolites are detected regularly in aquatic and terrestrial environments [15,16]. Hence, tertiary treatment is needed to eliminate these emerging pollutants.…”

Section: Introductionmentioning

confidence: 99%

Removal of Pharmaceuticals from Water by Adsorption and Advanced Oxidation Processes: State of the Art and Trends

et al. 2021

View full text Add to dashboard Cite

Pharmaceutical products have become a necessary part of life. Several studies have demonstrated that indirect exposure of humans to pharmaceuticals through the water could cause negative effects. Raw sewage and wastewater effluents are the major sources of pharmaceuticals found in surface waters and drinking water. Therefore, it is important to consider and characterize the efficiency of pharmaceutical removal during wastewater and drinking-water treatment processes. Various treatment options have been investigated for the removal/reduction of drugs (e.g., antibiotics, NSAIDs, analgesics) using conventional or biological treatments, such as activated sludge processes or bio-filtration, respectively. The efficiency of these processes ranges from 20–90%. Comparatively, advanced wastewater treatment processes, such as reverse osmosis, ozonation and advanced oxidation technologies, can achieve higher removal rates for drugs. Pharmaceuticals and their metabolites undergo natural attenuation by adsorption and solar oxidation. Therefore, pharmaceuticals in water sources even at trace concentrations would have undergone removal through biological processes and, if applicable, combined adsorption and photocatalytic degradation wastewater treatment processes. This review provides an overview of the conventional and advanced technologies for the removal of pharmaceutical compounds from water sources. It also sheds light on the key points behind adsorption and photocatalysis.

show abstract

The fate and risk assessment of psychiatric pharmaceuticals from psychiatric hospital effluent

Cited by 57 publications

References 57 publications

How to decrease pharmaceuticals in the environment? A review

How to decrease pharmaceuticals in the environment? A review

Nano-based adsorbent and photocatalyst use for pharmaceutical contaminant removal during indirect potable water reuse

Removal of Pharmaceuticals from Water by Adsorption and Advanced Oxidation Processes: State of the Art and Trends

Contact Info

Product

Resources

About